Literature DB >> 12372454

Characteristics of patients with endometriosis in the United States and the United Kingdom.

Wendy Kuohung1, Georgina L Jones, Allison F Vitonis, Daniel W Cramer, Stephen H Kennedy, Daniel Thomas, Mark D Hornstein.   

Abstract

OBJECTIVE: To investigate differences in characteristics of patients with endometriosis in the United States and the United Kingdom.
DESIGN: Patient questionnaire.
SETTING: Two university-based endometriosis referral centers. PATIENT(S): Women with surgically diagnosed endometriosis. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Patient demographics, menstrual and obstetric history, contraceptive use, medical history, risk factors, family history, endometriosis diagnosis, and current pain status and treatment. RESULT(S): Most demographic characteristics were similar between groups. However, patients in the United States were diagnosed at a younger age than were patients in the United Kingdom (25.6 +/- 6.7 years vs. 28.0 +/- 7.1 years) and more commonly presented with an ovarian mass. More U.K. women used oral contraceptives before diagnosis and were younger at first use. U.K. patients underwent fewer additional surgeries than U.S. patients but reported that surgery alone provided the best relief of symptoms, whereas most U.S. patients reported that surgical and medical therapy together provided the best relief of symptoms. CONCLUSION(S): The many similarities in demographics and symptoms among women with endometriosis in the U.S. and the U.K. support the universality of the disease process. Despite a variety of treatments, most patients from both groups still experienced pain from their endometriosis at the time of the survey.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372454     DOI: 10.1016/s0015-0282(02)03342-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

Review 1.  Endometriosis, need for a multidisciplinary clinical setting: the internist's point of view.

Authors:  Massimo Montalto; Luca Santoro; Ferruccio D'Onofrio; Antonella Gallo; Sebastiano Campo; Vincenzo Campo; Antonio Gasbarrini; Giovanni Gasbarrini
Journal:  Intern Emerg Med       Date:  2010-05-07       Impact factor: 3.397

Review 2.  [Endometriosis : An often unrecognized pain disorder].

Authors:  S Mechsner
Journal:  Schmerz       Date:  2016-10       Impact factor: 1.107

3.  Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.

Authors:  Sharif Sakr; Hanyia Naqvi; Barry Komm; Hugh S Taylor
Journal:  Endocrinology       Date:  2014-01-31       Impact factor: 4.736

Review 4.  Stem cells and the pathogenesis of endometriosis.

Authors:  Isaac E Sasson; Hugh S Taylor
Journal:  Ann N Y Acad Sci       Date:  2008-04       Impact factor: 5.691

5.  Characteristics of women with endometriosis from the USA and Puerto Rico.

Authors:  Jessica Fourquet; Ninet Sinaii; Pamela Stratton; Fareed Khayel; Carolina Alvarez-Garriga; Manuel Bayona; Mary Lou Ballweg; Idhaliz Flores
Journal:  J Endometr Pelvic Pain Disord       Date:  2015-10-01

6.  Graves Disease Is Associated With Endometriosis: A 3-Year Population-Based Cross-Sectional Study.

Authors:  Jin-Sung Yuk; Eun-Ju Park; Yong-Soo Seo; Hee Jin Kim; Seon-Young Kwon; Won I Park
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Lovastatin Reduces Stemness via Epigenetic Reprograming of BMP2 and GATA2 in Human Endometrium and Endometriosis.

Authors:  Mahdieh Taghizadeh; Mehrdad Noruzinia
Journal:  Cell J       Date:  2016-12-21       Impact factor: 2.479

8.  Caesalpinia sappan induces apoptotic cell death in ectopic endometrial 12Z cells through suppressing pyruvate dehydrogenase kinase 1 expression.

Authors:  Bo-Sung Kim; Tae-Wook Chung; Hee-Jung Choi; Sung-Jin Bae; Hye-Rin Cho; Syng-Ook Lee; Jung-Hye Choi; Jong Kil Joo; Ki-Tae Ha
Journal:  Exp Ther Med       Date:  2021-02-11       Impact factor: 2.447

9.  The peritoneum is both a source and target of TGF-β in women with endometriosis.

Authors:  Vicky J Young; Jeremy K Brown; Philippa T K Saunders; W Colin Duncan; Andrew W Horne
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.